| Dr Matthew J Sollis, PHARMD | |
|
760 E Main St, Lehi, UT 84043-2284 | |
| (801) 766-0355 | |
| Not Available |
| Full Name | Dr Matthew J Sollis |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 760 E Main St, Lehi, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841555810 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 6217940-1701 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew J Sollis, PHARMD 760 E Main St, Lehi, UT 84043-2284 Ph: (801) 766-0355 | Dr Matthew J Sollis, PHARMD 760 E Main St, Lehi, UT 84043-2284 Ph: (801) 766-0355 |
News Archive
Scientists from the University of Birmingham are carrying out pioneering research as part of a major £10 million study aimed at improving outcomes for patients who have suffered a traumatic injury.
The University of Louisville Hepatobiology and Toxicology Center of Biomedical Research Excellence has received $11.3 million in funding from the National Institutes of Health to support its research into liver-related illness for an additional five years.
Australian-based global oncology company, Sirtex Medical Limited (ASX: SRX), has announced the completion of patient recruitment for its global SIRFLOX clinical study which is aimed at expanding the clinical use of its SIR-spheres® microspheres targeted radiation therapy from a last line medical treatment to a standard first-line oncology therapy.
Cernostics Inc., a biotechnology firm specializing in advanced cancer diagnostics, and Geisinger Health System, a $2.1 billion integrated health services organization, today announced a partnership in personalized healthcare. They will focus on developing diagnostic technologies to detect subtle differences in the cellular and molecular makeup of patient tissue samples. These technologies promise to more effectively predict disease progression and identify patients who are most likely to be receptive to specific cancer treatments.
Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, today announced that Health Canada has granted the company clearance to sell SONOVA 400 in Canada. With the December 2009 completion of the New Dietary Ingredient (NDI) regulatory process in the United States, Arcadia is now able to make the health-maintaining oil available throughout the US and Canada.
› Verified 2 days ago
Mr. Jerry A Shields, R.PH.,M.B.A Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1584 W 900 N, Lehi, UT 84043 Phone: 801-580-4509 | |
Benjamin Foust, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1750 W Traverse Pkwy, Lehi, UT 84043 Phone: 385-352-8018 Fax: 385-352-8019 | |
Diane Bezzant Ogborn, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1550 E 3500 N, Lehi, UT 84043 Phone: 801-341-6515 Fax: 801-341-6516 | |
Timothy Nelson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 198 N 1200 E, Lehi, UT 84043 Phone: 801-653-2709 | |
Dr. Adam Wilson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1250 Bridalwood Loop, Lehi, UT 84043 Phone: 208-206-1568 | |
Dr. Jason Richard Cook I, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 102 N 1200 E, Lehi, UT 84043 Phone: 801-653-2090 | |
Ms. Jennifer Kay Homer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 590 E 1540 S, Lehi, UT 84043 Phone: 801-706-9726 |